Dyskinesia News and Research

RSS

Motor abnormalities may predict multiple mental health disorders

Motor issues-such as coordination problems, motor slowing, or sudden, uncontrolled movements-have been recognized as signs of psychological disorders since the 1800s. How they map to mental health conditions, however, remains unknown.

22 Jul 2026

New drug candidate improves Parkinson's treatment in animal models

For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen.

15 Jul 2026

Oral swab detects hidden inflammation in rare lung disease

Researchers at UTHealth Houston have identified different types of hidden systemic inflammation in patients with primary ciliary dyskinesia, even when they are not experiencing acute illness.

9 Jun 2026

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.

5 Feb 2026

Engineers create designer biobots using human lung cells

A brand-new engineering approach to generate "designer" biological robots using human lung cells is underway in Carnegie Mellon University's Ren lab.

26 Sep 2025

Researchers map atomic structure of protein complex driving cilia movement

A team led by UT Southwestern Medical Center researchers has uncovered the atomic structure of a protein complex pivotal to the function of motile cilia, the hair-like structures extending from the surfaces of many cell types that generate their movement.

28 Jul 2025

iPS cell transplants show early promise for treating Parkinson's disease safely

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with Parkinson’s disease and observed promising motor improvements with no serious safety concerns over 24 months. The therapy showed increased dopamine synthesis without tumor formation or graft-induced dyskinesia.

21 Apr 2025

Stem cell therapy shows promise for treating advanced Parkinson's disease

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical trial reported in Nature.

16 Apr 2025

New guidelines aim to improve diagnosis and treatment of mycoplasma pneumoniae in children

The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.

7 Apr 2025

Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.

6 Jan 2025

New insights into uncontrollable movements in Parkinson's disease patients

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of treatment.

3 Jan 2025

Study identifies ophthalmic acid as an alternative to dopamine in motor control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.

4 Oct 2024

Research reveals key role of mucin modification in muco-obstructive diseases

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of the first lines of defense and aids in removal these microbes.

24 Sep 2024

Air pollution drives higher Parkinson’s risk and worsens symptoms in affected patients

Higher air pollution levels, particularly PM2.5 and NO2, significantly increase the risk of Parkinson's disease and worsen clinical outcomes like dyskinesia.

17 Sep 2024

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease.

22 Aug 2024

Questioning the effectiveness of cholecystectomy for functional gallbladder disorder

Although surgery is a common treatment for patients diagnosed with biliary dyskinesia, or functional gallbladder disorder, a West Virginia University medical researcher is questioning why the practice has become so widespread when little clinical research is available.

20 Aug 2024